Video

Factors That Could Impact Specialty Pharmacy Patients

Author(s):

Lauren Santye, Assistant Editor

Suzette DiMascio, CHE, CMCE, CPC, president and CEO of CSI Specialty Group, discusses high drug costs and the specialty pharmacy patient.

Suzette DiMascio, CHE, CMCE, CPC, president and CEO of CSI Specialty Group, discusses high drug costs and the specialty pharmacy patient.

Related Videos
Abstract DNA molecule helix inside red blood drop
Woman experiencing pain from UTI -- Image credit: 220 Selfmade studio | stock.adobe.com
Related Content
Health care professional and model of a kidney -- Image credit: manassanant | stock.adobe.com
March 13th 2025

Updated CKD Guidelines Emphasize Implementation of Evidence-Based Approaches

Gillian McGovern, Associate Editor
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
February 28th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
Psoriasis skin. Closeup of rash and scaling on the patient's skin. The concept of chronic disease treatment. Dermatological problems. Hard, horny and cracked skin in woman's hands.
March 10th 2025

Icotrokinra Demonstrates Meaningful Skin Clearance in Moderate-to-Severe Plaque Psoriasis

Luke Halpern, Assistant Editor
Pharmacy Focus: Oncology Edition - Discussing Increasing Rates of Lung Cancer in Young Adults and Emerging Precision Treatments
November 25th 2024

Pharmacy Focus: Oncology Edition - Discussing Increasing Rates of Lung Cancer in Young Adults and Emerging Precision Treatments

uman papillomavirus infection. Virus. HPV is the most common sexually transmitted infection globally. HPV infection is caused by human papillomavirus, a DNA virus from the papillomavirus family
March 7th 2025

First-in-Kind Trametinib Antiviral Gel Can Fight HPV Precancers and Prevent Progression

Luke Halpern, Assistant Editor
FDA seal of approval -- Image credit: Aquir | stock.adobe.com
March 6th 2025

FDA Approves Expansion for Furosemide Injection to Treat Edema In Patients With CKD

Gillian McGovern, Associate Editor